Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: a case-control study

Characteristics

Total (n = 100)

Median (IQR)/N (%)

Non-NS group (n = 50)

Median (IQR)/N (%)

NS group (n = 50)

Median (IQR)/N (%)

p value

Age, years

47(40–52)

47(40–52)

47(40–54)

0.953

Gender

   

0.106

 Female

25 (25.0%)

16(32.0%)

9(18.0%)

 

 Male

75 (75.0%)

34(68.0%)

41(82.0%)

 

Domicile place

   

0.585

 Guangdong Province

84 (84.0%)

41(82.0%)

43(86.0%)

 

 Other provinces

16 (16.0%)

9(18.0%)

7(14.0%)

 

Marital status

   

0.025

 Single

11 (11.0%)

9(18.0%)

2(4.0%)

 

 Married

89 (89.0%)

41(82.0%)

48(96.0%)

 

Occupation

   

0.418

 Permanent job

58 (58.0%)

31(62.0%)

27(54.0%)

 

 Temporary job

42 (42.0%)

19(38.0%)

23(46.0%)

 

Neurological symptoms

28 (28.3%)

5(10.2%)

23(46.0%)

< 0.001

Serum TRUST titer

1:8 (1:4–1:16)

1:4 (1:2–1:16)

1:16(1:8–1:32)

< 0.001

Serum TPPA titer

1:1280 (> 1:1280–1:1280)

1:1280 (1:1280–1:1280)

> 1:1280 (> 1:1280–1:1280)

0.006

Serum TP-IgM

31(41.9%)

9(27.3%)

22(53.7%)

0.022

CSF TRUST titer

Neg (Neg- Neg)

Neg (Neg- Neg)

1:2 (Neg-1:4)

< 0.001

CSF TPPA titer

1:640 (Neg-1:1280)

Neg (Neg-1:160)

1:1280 (1:1280–1:1280)

< 0.001

CSF protein, mg/L

365.0 (270.0–598.9)

377.6(237.0–421.2)

521.5 (300.5–796.0)

< 0.001

CSF WBC, cells/μL

1 (0–5)

0(0–5)

3(0–10)

0.005

CSF glucose, mmol/L

3.61 (3.30–4.00)

3.70 (3.35–4.00)

3.5(3.2–3.9)

0.036

CSF chlorides, mmol/L

120.0 (117.0–122.0)

121.0(117.8–124.5)

118.1(115.8–122.0)

0.009

  1. NS Neurosyphilis, TRUST Toludine red unheated serum test, TPPA Treponema pallidum particle agglutination, TP-IgM Treponema pallidum IgM, CSF Cerebrospinal fluid, Neg Negative, WBC White blood cell. Median and interquartile range (IQR) were used to describe continuous variables, while frequencies and percentages were used to describe categorical variables